David Novack compensation by year
DYNAVAX TECHNOLOGIES Summary Compensation Table · all 4 fiscal years held| Component | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Salary | $519,750 | $545,738 | $570,296 | $593,108 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $935,025 | $645,540 | $885,125 | $2,016,121 |
| Option awards | $1,013,100 | $1,208,685 | $1,094,625 | $750,253 |
| Non-equity incentive | $436,590 | $366,736 | $427,722 | $364,762 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $13,635 | $13,124 | $15,563 | $7,443 |
| Total | $2,918,100 | $2,779,823 | $2,993,331 | $3,731,687 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DYNAVAX TECHNOLOGIES CORP DEF 14A filed April 17, 2025, accession 0000930413-25-001273, and prior-year filings.
How this page was built: the DYNAVAX TECHNOLOGIES CORP filed document, accession 0000930413-25-001273. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 67,860 | $866,572 | — |
| PSU | 67,860 | $866,572 | — |
| PSU | 48,500 | $619,345 | — |
| PSU | 26,500 | $338,405 | — |
| RSU | 8,833 | $112,797 | — |
| Option | 95,000 | — | $12.48 |
| Option | 58,334 | — | $11.12 |
| Option | 8,334 | — | $12.74 |
Per the Outstanding Equity Awards at Fiscal Year-End table in DYNAVAX TECHNOLOGIES CORP's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
30 Form 4 lines since the FY2024 proxy (filed April 17, 2025)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-02-10 | Grant or award | — | 67,860 | — | 67,860 |
| 2026-02-10 | U | — | 63,334 | — | 0 |
| 2026-02-10 | Disposition to the issuer | — | 67,860 | — | 0 |
| 2026-02-10 | Disposition to the issuer derivative | — | 150,000 | — | 0 |
| 2026-02-10 | Disposition to the issuer derivative | — | 150,000 | — | 0 |
| 2026-02-10 | Grant or award | — | 56,364 | — | 56,364 |
| 2026-02-10 | Disposition to the issuer derivative | — | 95,000 | — | 0 |
| 2026-02-10 | Disposition to the issuer | — | 56,364 | — | 0 |
The 8 most recent of 30 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
DYNAVAX TECHNOLOGIES’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Ryan Spencer | Chief Executive Officer and Director | $8,210,775 |
| David Novack · this page | President and Chief Operating Officer | $3,731,687 |
| John Slebir | Senior Vice President and General Counsel | $2,847,447 |
| Kelly MacDonald | Senior Vice President and Chief Financial Officer | $2,626,267 |
| Robert Janssen | Chief Medical Officer and Senior Vice President | $2,283,533 |
David Novack's compensation dossier, DYNAVAX TECHNOLOGIES
You have read David Novack's totals and holdings. The dossier adds each equity grant DYNAVAX TECHNOLOGIES disclosed for David Novack and DYNAVAX TECHNOLOGIES's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full DYNAVAX TECHNOLOGIES compensation record
free company briefThis page is one person within DYNAVAX TECHNOLOGIES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the DYNAVAX TECHNOLOGIES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order DYNAVAX TECHNOLOGIES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are DYNAVAX TECHNOLOGIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.